×

img Acces sibility Controls

Technologies Banner

Life Sciences & Biotechnology

DNA Vaccine as Immune-prophylaxis Against Kala-azar

Implementing Organization

Indian Institute of Chemical Engineers
Indian Institute of Chemical Biology (IICB)

About

The technology uses a highly conserved membrane protein present in all species of Leishmania as a vaccine antigen for genetic immunization against visceral leishmananiasis or Kala-azar.

Patent Details

US8524677
Funding Organization
Funding Organization

Quick Information
Area of Research
Medical Sciences
Focus Area
Genetic Immunization against Kala-azar
Status
completed
Patent No.
US8524677
Output in Numbers
Research Paper
00
Technologies (If Any)
00
PhD Produced
N/A
Startup (If Any)
00
Patents
Filed :01
Grant :00
arrowtop